Caption Management, LLC Beam Therapeutics Inc. Put Options Transaction History

Caption Management, LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$22.57 - $33.14 $451,400 - $662,800	20,000 Added 200.0%	30,000 $735,000
Q2 2024 Aug 14, 2024	SELL	$21.22 - $32.66 $530,500 - $816,499	-25,000 Reduced 71.43%	10,000 $234,000
Q1 2024 May 15, 2024	BUY	$23.46 - $45.07 $821,100 - $1.58 Million	35,000 New	35,000 $1.16 Million
Q4 2022 Feb 14, 2023	BUY	$36.73 - $51.6 $734,599 - $1.03 Million	20,000 New	20,000 $782,000
Q4 2021 Feb 11, 2022	SELL	$68.02 - $99.06 $1.02 Million - $1.49 Million	-15,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$84.37 - $133.6 $1.27 Million - $2 Million	15,000 New	15,000 $1.31 Million
Q2 2021 Aug 16, 2021	SELL	$64.12 - $128.71 $1.6 Million - $3.22 Million	-25,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$71.28 - $120.75 $1.78 Million - $3.02 Million	25,000 New	25,000 $2 Million

236

75.2M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.78B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.